Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")
Clinical trial NCT07411599 · RECRUITING
Trial details
- NCT number
- NCT07411599
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-20
- Primary completion
- 2028-11-15
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.